Loading the records…
Loading the records…
S. 4451 is an early-stage authorization bill for wildlife health coordination and zoonotic disease prevention. It authorizes no specific dollar amount and contains no mandatory spending, procurement mandates, or regulatory obligations. At this stage, it has negligible near-term market impact on healthcare, agricultural, or technology companies.
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
The market should not react to this bill. It is a procedural authorizing bill with no dollar amount, no mandatory spending, and no regulatory mandate. There is no mechanism that changes revenue, costs, or competitive dynamics for any public company. Investors tracking healthcare policy should watch for an appropriations bill or a committee markup that includes specific funding levels — neither exists for S. 4451.
On April 30, 2026, Sen. Tammy Baldwin (D-WI) introduced S. 4451, the Wildlife Health Coordination and Zoonotic Disease Prevention Act of 2026, in the Senate. The bill was read twice and referred to the Committee on Environment and Public Works. As an authorization bill with zero explicit funding amounts, it does not allocate any budget authority. It proposes establishing coordination frameworks among Federal, State, and Tribal agencies for wildlife disease and zoonotic disease surveillance, but all spending would require subsequent appropriations bills, which have not been introduced. Because the bill remains at the earliest legislative stage with only two actions (both on the date of introduction), there is no legislative momentum. Without markup, committee report, or companion House bill, the probability of passage in its current form is extremely low. Even if passed, the authorization would simply grant permission for future appropriations — a process that typically takes 12-24 months. For companies in the diagnostic, veterinary vaccine, and health services space, the bill offers no revenue certainty. The tickers listed above are neutral because the mechanism (competitive grants for R&D and surveillance) is too small relative to their overall revenue to move financial results. The entire healthcare sector has $54B-$371B annual revenues among the listed companies; a potential grant pool in the tens of millions would register <0.1% of revenue for any of them. No real market data on stock price movements is available because no market-moving event has occurred.
Matched on shared policy language across AI analyses, with ticker & timing weight
MERCK SHARP & DOHME LLC: $1.8B Department of Health and Human Services Contract Vehicle
OHIO DEPARTMENT OF MEDICAID: $28.2B Department of Health and Human Services Grant
MULTIPLE RECIPIENTS: $1.2B Department of Health and Human Services Federal Award
MULTIPLE RECIPIENTS: $2.1B Department of Health and Human Services Federal Award
MULTIPLE RECIPIENTS: $4.6B Department of Health and Human Services Federal Award
MULTIPLE RECIPIENTS: $4.6B Department of Health and Human Services Federal Award
MULTIPLE RECIPIENTS: $4.0B Department of Health and Human Services Federal Award
MULTIPLE RECIPIENTS: $1.4B Department of Health and Human Services Federal Award
Executive orders & memoranda affecting the same sectors or companies
This executive order establishes a Women's Health Division within the NIH to coordinate and accelerate research on understudied women's health conditions, and creates a White House Women's Health Task Force to drive policy reforms and translation of research into clinical practice across federal agencies. It directs specific agencies to prioritize research, data collection, and translation into prevention, diagnosis, and treatment, with a focus on all life stages from infancy through aging.
This executive order directs the Secretaries of State, Labor, and Homeland Security to coordinate with Commerce, Education, and the SBA when processing H-1B petitions, and requires them to consider whether the employer has engaged in layoffs of similarly situated U.S. workers within the past year. It also orders the Labor Department to review past labor condition applications for potential enforcement actions against sponsoring employers, effectively tightening scrutiny on H-1B usage, especially by outsourcing firms.
This executive order revokes Executive Order 13508, which had mandated Chesapeake Bay restoration efforts, and directs federal agencies to prioritize funding for direct, on-the-ground water quality projects. It also instructs the EPA to work with states to assess and encourage the repeal of stormwater management fees (rain taxes) that have burdened residents, aiming to reduce costs while maintaining environmental progress.
Free — no credit card
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →